Nielka V. E.
- Country
- The Netherlands
- Department
- Pharmacy
Research Overview
- Evaluation of Regorafenib, Vemurafenib, and Dacomitinib in Advanced Solid Tumors, Multiple Myeloma, and Non-Hodgkin Lymphoma with Targetable Genomic Variants
- Evaluation of Enzalutamide's Impact on Edoxaban and Morphine Pharmacokinetics in Prostate Cancer Patients
- Evaluation of Image-Guided De-Escalation of Neoadjuvant Chemotherapy with Trastuzumab, Pertuzumab, and Drug Combination in HER2-Positive Breast Cancer
Data & Insights
Has run more than one trial at 125 of 222 partner sites.
Specializations
Oncology Research
This investigator specializes in prostate cancer treatment optimization, with particular emphasis on understanding drug interactions in cancer therapy.
- Advanced prostate cancer management
- Therapeutic drug monitoring
- Oncological pharmacology
The research focuses on improving treatment outcomes for prostate cancer patients through enhanced understanding of medication interactions.
Clinical Pharmacology
The investigator studies drug-drug interactions between cancer treatments and commonly prescribed medications, particularly in the context of anticoagulation and pain management.
- Medication interaction analysis
- Pharmacokinetic studies
- Drug exposure assessment
Their work examines the clinical implications of concurrent medication use in cancer treatment.
Treatment Optimization
The investigator's work centers on rational pharmacological care for cancer patients who require multiple medications.
- Treatment safety enhancement
- Clinical relevance assessment
- Patient care optimization
The research aims to enhance treatment safety and efficacy through better understanding of medication interactions.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.